Safety, Tolerability, and Pharmacokinetics of IXT-m200
Clinical trial NCT05027451 · COMPLETED
Trial details
- NCT number
- NCT05027451
- Sponsor
- InterveXion Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2022-03-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.